{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:28:51Z","timestamp":1772753331913,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T00:00:00Z","timestamp":1269388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-111","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T03:16:45Z","timestamp":1269487005000},"source":"Crossref","is-referenced-by-count":60,"title":["A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)"],"prefix":"10.1186","volume":"10","author":[{"given":"Gina S","family":"Ogilvie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J","family":"van Niekerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth E","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G","family":"Ehlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie W","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrel A","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin CE","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo L","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Coldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"issue":"7","key":"1910_CR1","first-page":"1017","volume":"164","author":"EL Franco","year":"2001","unstructured":"Franco EL, Duarte-Franco E, Ferenczy A: Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001, 164 (7): 1017-1025.","journal-title":"CMAJ"},{"issue":"10","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","volume":"132","author":"K Nanda","year":"2000","unstructured":"Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselbad V, Hickey JD, et al: Accuracy of the Papanicoloau test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine. 2000, 132 (10): 810-819.","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"1910_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","volume":"141","author":"MT Fahey","year":"1995","unstructured":"Fahey MT, Irwig L, Macaskill P: Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995, 141 (7): 680-689.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.[comment]. J Pathol. 1999, 189 (1): 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"issue":"6","key":"1910_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"issue":"2","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","volume":"103","author":"TC Wright Jr","year":"2004","unstructured":"Wright TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al: Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstetrics & Gynecology. 2004, 103 (2): 304-309.","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cncr.22751","volume":"111","author":"M Schiffman","year":"2007","unstructured":"Schiffman M: Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer. 2007, 111 (3): 145-153. 10.1002\/cncr.22751.","journal-title":"Cancer"},{"issue":"9","key":"1910_CR8","first-page":"945","volume":"9","author":"S Ratnam","year":"2000","unstructured":"Ratnam S, Franco EL, Ferenczy A: Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 945-951.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9399","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","volume":"362","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al: Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003, 362 (9399): 1871-1876. 10.1016\/S0140-6736(03)14955-0.","journal-title":"Lancet"},{"key":"1910_CR10","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136\/bmj.a1754.","journal-title":"BMJ"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a003488","volume":"31","author":"EL Franco","year":"2003","unstructured":"Franco EL: Chapter 13: Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr. 2003, 31: 89-96.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"7","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S1470-2045(06)70735-5","volume":"7","author":"EL Franco","year":"2006","unstructured":"Franco EL, Ferenczy A, Franco EL: Is HPV testing with cytological triage a more logical approach in cervical cancer screening?. Lancet Oncology. 2006, 7 (7): 527-529. 10.1016\/S1470-2045(06)70735-5.","journal-title":"Lancet Oncology"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.vaccine.2007.11.069","volume":"26 Supp 1A","author":"EL Franco","year":"2008","unstructured":"Franco EL, Cuzick J: Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine. March 14, 2008, 26 Supp 1A: 16-23. 10.1016\/j.vaccine.2007.11.069.","journal-title":"Vaccine"},{"issue":"8","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","volume":"93","author":"L Kotaniemi-Talonen","year":"2005","unstructured":"Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M, et al: Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. British Journal of Cancer. 2005, 93 (8): 862-867. 10.1038\/sj.bjc.6602799.","journal-title":"British Journal of Cancer"},{"issue":"4","key":"1910_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ejca.2007.12.002","volume":"44","author":"L Kotaniemi-Talonen","year":"2008","unstructured":"Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, et al: Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. European Journal of Cancer. 2008, 44 (4): 565-571. 10.1016\/j.ejca.2007.12.002.","journal-title":"European Journal of Cancer"},{"issue":"9601","key":"1910_CR16","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007, 370 (9601): 1764-1772. 10.1016\/S0140-6736(07)61450-0.","journal-title":"Lancet"},{"issue":"1","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","volume":"95","author":"HC Kitchener","year":"2006","unstructured":"Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, et al: HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. British Journal of Cancer. 2006, 95 (1): 56-61. 10.1038\/sj.bjc.6603210.","journal-title":"British Journal of Cancer"},{"issue":"16","key":"1910_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al: Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007, 357 (16): 1589-1597. 10.1056\/NEJMoa073204.","journal-title":"N Engl J Med"},{"issue":"16","key":"1910_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.[see comment]. N Engl J Med. 2007, 357 (16): 1579-1588. 10.1056\/NEJMoa071430.","journal-title":"N Engl J Med"},{"issue":"7","key":"1910_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del Mistro A, et al: Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008, 100 (7): 492-501. 10.1093\/jnci\/djn065.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"1910_CR21","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/ijc.23055","volume":"121","author":"P Giorgi-Rossi","year":"2007","unstructured":"Giorgi-Rossi P, Segnan N, Zappa M, Naldoni C, Zorzi M, Confortini M, et al: The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective. International Journal of Cancer. 2007, 121 (12): 2729-2734. 10.1002\/ijc.23055.","journal-title":"International Journal of Cancer"},{"key":"1910_CR22","volume-title":"Cervical Cancer Screening Program Annual Report","author":"BC Cancer Agency","year":"2008","unstructured":"BC Cancer Agency: Cervical Cancer Screening Program Annual Report. 2008, Vancouver, BC, BC Cancer Agency"},{"issue":"16","key":"1910_CR23","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002, 287 (16): 2114-2119. 10.1001\/jama.287.16.2114.","journal-title":"JAMA"},{"key":"1910_CR24","volume-title":"2005 Annual Report, Cervical Cancer Screening Program","author":"British Columbia Cancer Agency","year":"2005","unstructured":"British Columbia Cancer Agency: 2005 Annual Report, Cervical Cancer Screening Program. 2005, Vancouver, BC"},{"issue":"3","key":"1910_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/ijc.21897","volume":"119","author":"MH Mayrand","year":"2006","unstructured":"Mayrand MH, Duarte-Franco E, Coutlee F, Rodrigues I, Walter SD, Ratnam S, et al: Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). International Journal of Cancer. 2006, 119 (3): 615-623. 10.1002\/ijc.21897.","journal-title":"International Journal of Cancer"},{"key":"1910_CR26","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"2000","unstructured":"Rosner B: Fundamentals of Biostatistics. 2000, Pacific Grove, California, Fifth","edition":"Fifth"},{"issue":"9505","key":"1910_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0140-6736(06)67961-0","volume":"367","author":"E Davey","year":"2006","unstructured":"Davey E, Barratt A, Irwig L, Chan SF, Macaskill P, Mannes P, et al: Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet. 2006, 367 (9505): 122-132. 10.1016\/S0140-6736(06)67961-0.","journal-title":"Lancet"},{"issue":"7609","key":"1910_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","volume":"335","author":"G Ronco","year":"2007","unstructured":"Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla PP, Naldoni C, et al: Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ. 2007, 335 (7609): 28-10.1136\/bmj.39196.740995.BE.","journal-title":"BMJ"},{"issue":"16","key":"1910_CR29","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.2009.1569","volume":"302","author":"AG Siebers","year":"2009","unstructured":"Siebers AG, Klinkhamer PJJM, Grefte JMM, Massuger LFAG, Vedder JEM, Beijers-Broos A, et al: Comparison of Liquid-Based Cytology with Conventional Cytology for Detection of Cervical Cancer Precursors: A Randomized Trial. JAMA. 2009, 302 (16): 1757-1764. 10.1001\/jama.2009.1569.","journal-title":"JAMA"},{"issue":"8","key":"1910_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10552-009-9365-4","volume":"20","author":"RA Moore","year":"2009","unstructured":"Moore RA, Ogilvie GS, Fornika D, Moravan V, Brisson M, Amirabbasi-Beik M, Kollar A, et al: Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women-implications for vaccination. Cancer Causes Control. 2009, 20 (8): 1387-1396. 10.1007\/s10552-009-9365-4.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"1910_CR31","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/ijc.23670","volume":"123","author":"M Leinonen","year":"2008","unstructured":"Leinonen M, Kotaniemi-Talonen L, Anttila A, Dyba T, Tarkkanen J, Nieminen P: Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. International Journal of Cancer. 2008, 123 (6): 1344-1349. 10.1002\/ijc.23670.","journal-title":"International Journal of Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-111\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T02:32:29Z","timestamp":1497839549000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-111","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,24]]},"article-number":"111"}}